Autolus Therapeutics Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia By Investing.com
Autolus Therapeutics (AUTL) Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia Autolus Therapeutics plc (Nasdaq: NASDAQ:), a clinical-stage ...